icon is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. we specialise in the strategic development, management and analysis of programmes that support clinical development - from compound selection to phase i-iv clinical studies. in a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis. we have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution. we are also an 'end-to-end' pharmacovigilance service provider and this includes post marketing surveillance activities too.
Company profile
Ticker
ICLR
Exchange
Website
CEO
Stephen Cutler
Employees
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Medpace • Incyte • Zymergen • OmniAb • SomaLogic ...
Former names
ICON PLC /ADR/
SEC CIK
Corporate docs
IRS number
981067160
ICLR stock data
Latest filings (excl ownership)
6-K
ICON Announces CFO Transition
3 Apr 24
6-K
ICON plc Schedules First Quarter 2024 Earnings Conference Call
25 Mar 24
6-K
ICON plc to Present at Upcoming Investor Conferences
26 Feb 24
20-F
2023 FY
Annual report (foreign)
23 Feb 24
6-K
ICON Reports Fourth Quarter and Full Year 2023 Results
21 Feb 24
6-K
Icon PLC 6-K
30 Jan 24
6-K
Icon PLC 6-K
9 Jan 24
6-K
Icon PLC 6-K
4 Jan 24
6-K
Icon PLC 6-K
7 Dec 23
6-K
Icon PLC 6-K
8 Nov 23
Transcripts
ICLR
Earnings call transcript
2023 Q2
27 Jul 23
ICLR
Earnings call transcript
2023 Q1
27 Apr 23
ICLR
Earnings call transcript
2022 Q4
23 Feb 23
ICLR
Earnings call transcript
2022 Q3
6 Nov 22
ICLR
Earnings call transcript
2022 Q2
28 Jul 22
ICLR
Earnings call transcript
2022 Q1
28 Apr 22
ICLR
Earnings call transcript
2021 Q4
22 Feb 22
ICLR
Earnings call transcript
2021 Q3
6 Nov 21
ICLR
Earnings call transcript
2021 Q2
22 Jul 21
ICLR
Earnings call transcript
2021 Q1
1 May 21
Latest ownership filings
144
Notice of proposed sale of securities
18 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
144
Notice of proposed sale of securities
26 Feb 24
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 288.77 mm | 288.77 mm | 288.77 mm | 288.77 mm | 288.77 mm | 288.77 mm |
Cash burn (monthly) | 154.48 mm | 8.92 mm | (no burn) | (no burn) | 19.81 mm | (no burn) |
Cash used (since last report) | 2.42 bn | 139.67 mm | n/a | n/a | 310.04 mm | n/a |
Cash remaining | -2.13 bn | 149.10 mm | n/a | n/a | -21.28 mm | n/a |
Runway (months of cash) | -13.8 | 16.7 | n/a | n/a | -1.1 | n/a |
Institutional ownership, Q3 2023
94.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 532 |
Opened positions | 67 |
Closed positions | 47 |
Increased positions | 178 |
Reduced positions | 192 |
13F shares | Current |
---|---|
Total value | 18.46 tn |
Total shares | 78.19 mm |
Total puts | 66.30 k |
Total calls | 77.80 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
WCM Investment Management | 7.59 mm | $1.87 tn |
Massachusetts Financial Services | 6.06 mm | $1.49 tn |
Wellington Management | 3.35 mm | $825.31 bn |
FMR | 3.12 mm | $769.32 bn |
Lazard Asset Management | 3.05 mm | $750.08 mm |
Boston Partners | 2.89 mm | $710.67 bn |
Ninety One UK | 2.60 mm | $639.66 bn |
Capital Research Global Investors | 2.02 mm | $498.19 bn |
BEN Franklin Resources | 1.88 mm | $462.94 bn |
IVZ Invesco | 1.85 mm | $455.51 bn |
News
Here's How Much You Would Have Made Owning Icon Stock In The Last 20 Years
12 Apr 24
Baird Maintains Outperform on Icon, Raises Price Target to $362
4 Apr 24
Mizuho Reiterates Buy on Icon, Maintains $346 Price Target
4 Apr 24
Here's How Much You Would Have Made Owning Icon Stock In The Last 15 Years
25 Mar 24
Here's How Much $100 Invested In Icon 20 Years Ago Would Be Worth Today
8 Mar 24
Press releases
ICON Announces CFO Transition
3 Apr 24
ICON plc Schedules First Quarter 2024 Earnings Conference Call
25 Mar 24
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
30 Jan 24
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
24 Jan 24